https://www.selleckchem.com/pr....oducts/Methazolaston
In the majority of patients this was reflected in an improvement in lung function. Aspergillus group FEV1 (1.44 ± 0.8 L vs 1.6 ± 0.8 L p less then 0.02), FVC (2.49 ± 1.08 L vs 2.8 ± 1.1 L p = 0.01), and PEF (260 ± 150L/min vs 297 ± 194ml/min p less then 0.02). Candida group FEV1 (1.6 ± 0.76 L vs 2.0 ± 0.72 L p less then 0.004), FVC (2.69 ± 0.91 L vs 3.13 ± 0.7 L p = 0.05), and PEF (271± 139L/min vs 333 ± 156 L/min p = 0.01). Side effects of treatment were common, but resolved on stopping treatment. This service improvement projec
Like
Comment
Share
